Elevated serum levels of inflammatory mediators involved in JAK–STAT signaling have been associated with immune dysregulation in diabetes, thus contributing to insulin resistance, β-cell dysfunction, and endothelial impairment [64,65]. This evidence concerns the gene SOAT1 and diabetes mellitus.